title: Rofecoxib as an alternative in aspirin hypersensitivity.
authors.affiliation: Department of Dermatology, University of Cologne, Joseph-Stelzmann-Str. 9, 50924 Cologne, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Hinrichs
authors.forename: A
authors.initials: A
authors.lastname: Ritzkowsky
authors.forename: N
authors.initials: N
authors.lastname: Hunzelmann
authors.forename: T
authors.initials: T
authors.lastname: Krieg
authors.forename: K
authors.initials: K
authors.lastname: Scharffetter-Kochanek
mesh_terms: D000328:Adult; D001241:Aspirin / Q000009:adverse effects*; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004342:Drug Hypersensitivity / Q000209:etiology*; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D007783:Lactones / Q000627:therapeutic use*; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases; D019233:Retreatment; D013450:Sulfones
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D007783:Lactones; D008565:Membrane Proteins; D013450:Sulfones; C116926:rofecoxib; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D001241:Aspirin